Read More Pharma Industry News FDA approves Iovance’s AMTAGVI: A breakthrough in melanoma treatment Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a trailblazer in the field of biotechnology focused on developing novel polyclonal tumor… byPallavi MadhirajuFebruary 18, 2024